Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Neumora Therapeutics's NMRA-511?
NMRA-511 is a small molecule commercialized by Neumora Therapeutics, with a leading Phase I program in Alzheimer's Disease. According to...